tirzepatide vs semaglutide comparison weight loss efficacy side effects for in Adults With Overweight or Obesity Comparative safety and side effects

AMG 133 (now known as maridebart cafraglutide) is an optimized GIPR/GLP-1R bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR-Ab with two GLP-1 analogue agonist peptides using amino acid linkers

BMC Psychiatry, 16 (1), 341

In addition, many cardiologists think prescribing GLP-1 RAs should be the domain of endocrinologists, even though there is an unequivocal body of evidence demonstrating cardiovascular efficacy, and recommendations for prescription are now in every guideline and professional society recommendation for cardiology, which parallel the recommendations from endocrinology and primary care societies

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy complications

Fischman CM, Udey MC, Kurtz M, Wedner HJ